Cargando…

Poor adherence is a contributor to viral breakthrough in patients with chronic hepatitis B

OBJECTIVE: The objective of this study was to explore the risk factors of poor adherence of nucleoside analogs (NUC) treatment in chronic hepatitis B (CHB) patients and the virological changes in patients with poor adherence. SUBJECTS AND METHODS: A total of 205 CHB patients were enrolled. The patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Liguo, Chen, Peng, Zheng, Chao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233945/ https://www.ncbi.nlm.nih.gov/pubmed/30519055 http://dx.doi.org/10.2147/IDR.S186719

Ejemplares similares

Adherence to Medication Is a More Important Contributor to Viral Breakthrough in Chronic Hepatitis B Patients Treated with Entecavir Than in Those with Lamivudine
por: Kamezaki, Hidehiro, et al.
Publicado: (2013)

Hepatitis B viral breakthrough associated with inappropriate preservation of entecavir
por: Karabay, Oguz, et al.
Publicado: (2012)

Adherence to Anti-Viral Treatment for Chronic Hepatitis B
por: Abu-Freha, Naim, et al.
Publicado: (2020)

Breakthroughs and challenges in the management of pediatric viral hepatitis
por: Nicastro, Emanuele, et al.
Publicado: (2021)

Poor adherence and low persistency rates for hepatocellular carcinoma surveillance in patients with chronic hepatitis B
por: Wang, Christina, et al.
Publicado: (2016)

Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors
por: Polonsky, William H, et al.
Publicado: (2016)

Virologic response and breakthrough in chronic hepatitis B Egyptian patients receiving lamivudine therapy
por: Ismail, Sohair, et al.
Publicado: (2014)

Association of virological breakthrough and clinical outcomes in entecavir-treated HBeAg-positive chronic hepatitis B
por: Huang, Yi-Jie, et al.
Publicado: (2019)

Adherence in chronic hepatitis B: associations between medication possession ratio and adverse viral outcomes
por: Allard, Nicole L., et al.
Publicado: (2020)

Virologic breakthrough in a patient with chronic hepatitis B by combination treatment with tenofovir disoproxil fumarate and entecavir
por: Suzuki, Fumitaka, et al.
Publicado: (2014)

Assessment of Adherence to Prescribed Therapy in Patients with Chronic Hepatitis B
por: Abreu, Rodrigo Martins, et al.
Publicado: (2016)

Assessment of Adherence to Clinical Guidelines in Patients with Chronic Hepatitis B
por: Katwaroe, Warshan K., et al.
Publicado: (2022)

Contributors to and Consequences of Poor Sleep in Older Adults: Biopsychosocial Perspectives
por: Spira, Adam, et al.
Publicado: (2020)

On-treatment HBV DNA dynamics predict virological breakthrough in entecavir-treated HBeAg-positive chronic hepatitis B
por: Huang, Yi-Jie, et al.
Publicado: (2017)

Diagnostic value of circulating miRNA-122 for hepatitis B virus and/or hepatitis C virus-associated chronic viral hepatitis
por: Zhou, Xinhao, et al.
Publicado: (2019)

Adherence to Nucleoside/Nucleotide Analogue Treatment in Patients with Chronic Hepatitis B
por: Tütüncü, Emin Ediz, et al.
Publicado: (2017)

Vitamin D status in critical care: Contributor or marker of poor health?
por: Amrein, Karin
Publicado: (2014)

Quantified integrated hepatitis B virus is related to viral activity in patients with chronic hepatitis B
por: Erken, Robin, et al.
Publicado: (2022)

Contributors
Publicado: (2009)

To Contributors
Publicado: (1859)

To Contributors
Publicado: (1871)

To Contributors
Publicado: (1867)

To Contributors
Publicado: (1891)

To Contributors
Publicado: (1886)

To Contributors
Publicado: (1884)

Effects of comprehensive intervention on health-related quality of life in patients with chronic hepatitis B in China
por: Chao, Jianqian, et al.
Publicado: (2013)

Clinical Diagnostic Value of Quantitative Hepatitis B Virus Core Antibody Test in Chronic Viral Hepatitis B
por: Su, Xi, et al.
Publicado: (2021)

Special Issue “Hepatitis B Virus: New Breakthroughs to Conquer an Ancient Disease”
por: Tu, Thomas, et al.
Publicado: (2023)

Hepatitis B core-related antigen reflects viral replication and protein production in chronic hepatitis B patients
por: Li, Jun, et al.
Publicado: (2021)

Hospitalized patients with breakthrough COVID-19: Clinical features and poor outcome predictors
por: Moreno-Perez, Oscar, et al.
Publicado: (2022)

Adherence to Treatment with Oral Nucleoside/Nucleotide Analogs in Patients with Chronic Hepatitis B
por: Ozyigitoglu, Derya, et al.
Publicado: (2022)

Relationship between gut microbiome diversity and hepatitis B viral load in patients with chronic hepatitis B
por: Joo, Eun-Jeong, et al.
Publicado: (2021)

Psychological Factors as Risk Contributors for Poor Hip Function after Periacetabular Osteotomy
por: Fischer, Maximilian, et al.
Publicado: (2023)

Adherence and perceived barriers to oral antiviral therapy for chronic hepatitis B
por: Xu, Kerui, et al.
Publicado: (2018)

TNFRSF13B is a potential contributor to prostate cancer
por: Li, Chia-Yang, et al.
Publicado: (2022)

Central obesity is a contributor to systemic inflammation and monocyte activation in virally suppressed adults with chronic HIV in Kenya
por: Temu, Tecla M., et al.
Publicado: (2021)

1448. Forgiveness of BIC/FTC/TAF: In Vitro Simulations of Intermittent Poor Adherence Find Limited HIV-1 Breakthrough and High Barrier to Resistance
por: Mulato, Andrew, et al.
Publicado: (2020)

Relationship between hepatitis B DNA viral load in the liver and its histology in patients with chronic hepatitis B
por: Biazar, Tahmineh, et al.
Publicado: (2015)

Hepatitis B Core Antigen Expression in Hepatocytes Reflects Viral Response to Entecavir in Chronic Hepatitis B Patients
por: Lee, Jeong Guil, et al.
Publicado: (2013)

Immune Mechanisms Underlying Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients With Viral Coinfection
por: Wu, Shuling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8rabv5h1vk2r465p44bh3eijh4